Law360, New York (May 30, 2007, 12:00 AM ET) -- Less than three weeks after a federal judge threw out an antitrust class action complaint against the maker of the bladder drug Ditropan XL, the plaintiffs filed an amended complaint Tuesday in a San Francisco federal court.
Both complaints accuse the makers and distributors of Ditropan XL of illegally trying to keep generic versions off the market by suing and entering into anti-competitive agreements with potential competitors.
But the new complaint contains some changes, including a second defendant, Ortho-McNeil Pharmaceuticals Inc.—the company that distributes Ditropan XL...
Amended Complaint Filed Over Ditropan
To view the full article, take a free trial now.
